TY - JOUR
T1 - Outwitting an old neglected nemesis
T2 - A review on leveraging integrated data-driven approaches to aid in unraveling of leishmanicides of therapeutic potential
AU - Kwofie, Samuel K.
AU - Broni, Emmanuel
AU - Dankwa, Bismark
AU - Enninful, Kweku S.
AU - Kwarko, Gabriel B.
AU - Darko, Louis
AU - Durvasula, Ravi
AU - Kempaiah, Prakasha
AU - Rathi, Brijesh
AU - Miller, Whelton A.
AU - Yaya, Abu
AU - Wilson, Michael D.
N1 - Publisher Copyright:
© 2020 Bentham Science Publishers.
PY - 2020
Y1 - 2020
N2 - The global prevalence of leishmaniasis has increased with skyrocketed mortality in the past decade. The causative agent of leishmaniasis is Leishmania species, which infects populations in almost all the continents. Prevailing treatment regimens are consistently inefficient with reported side effects, toxicity and drug resistance. This review complements existing ones by discussing the current state of treatment options, therapeutic bottlenecks including chemoresistance and toxicity, as well as drug tar-gets. It further highlights innovative applications of nanotherapeutics-based formulations, inhibitory potential of leishmanicides, anti-microbial peptides and organometallic compounds on leishmanial species. Moreover, it provides essential insights into recent machine learning-based models that have been used to predict novel leishmanicides and also discusses other new models that could be adopted to develop fast, efficient, robust and novel algorithms to aid in unraveling the next generation of anti-leishmanial drugs. A plethora of enriched functional genomic, proteomic, structural biology, high throughput bioas-say and drug-related datasets are currently warehoused in both general and leishmania-specific data-bases. The warehoused datasets are essential inputs for training and testing algorithms to augment the prediction of biotherapeutic entities. In addition, we demonstrate how pharmacoinformatics techniques including ligand-, structure-and pharmacophore-based virtual screening approaches have been utilized to screen ligand libraries against both modeled and experimentally solved 3D structures of essential drug targets. In the era of data-driven decision-making, we believe that highlighting intricately linked topical issues relevant to leishmanial drug discovery offers a one-stop-shop opportunity to decipher critical lit-erature with the potential to unlock implicit breakthroughs.
AB - The global prevalence of leishmaniasis has increased with skyrocketed mortality in the past decade. The causative agent of leishmaniasis is Leishmania species, which infects populations in almost all the continents. Prevailing treatment regimens are consistently inefficient with reported side effects, toxicity and drug resistance. This review complements existing ones by discussing the current state of treatment options, therapeutic bottlenecks including chemoresistance and toxicity, as well as drug tar-gets. It further highlights innovative applications of nanotherapeutics-based formulations, inhibitory potential of leishmanicides, anti-microbial peptides and organometallic compounds on leishmanial species. Moreover, it provides essential insights into recent machine learning-based models that have been used to predict novel leishmanicides and also discusses other new models that could be adopted to develop fast, efficient, robust and novel algorithms to aid in unraveling the next generation of anti-leishmanial drugs. A plethora of enriched functional genomic, proteomic, structural biology, high throughput bioas-say and drug-related datasets are currently warehoused in both general and leishmania-specific data-bases. The warehoused datasets are essential inputs for training and testing algorithms to augment the prediction of biotherapeutic entities. In addition, we demonstrate how pharmacoinformatics techniques including ligand-, structure-and pharmacophore-based virtual screening approaches have been utilized to screen ligand libraries against both modeled and experimentally solved 3D structures of essential drug targets. In the era of data-driven decision-making, we believe that highlighting intricately linked topical issues relevant to leishmanial drug discovery offers a one-stop-shop opportunity to decipher critical lit-erature with the potential to unlock implicit breakthroughs.
KW - Drug resistance
KW - Leishmanicides
KW - Leveraging integrated data
KW - Machine learning
KW - Nanotherapeutics-based formulations
KW - Nemesis
KW - Organometallics
KW - Therapeutic potential
UR - http://www.scopus.com/inward/record.url?scp=85082979051&partnerID=8YFLogxK
U2 - 10.2174/1568026620666200128160454
DO - 10.2174/1568026620666200128160454
M3 - Review article
C2 - 31994465
AN - SCOPUS:85082979051
SN - 1568-0266
VL - 20
SP - 349
EP - 366
JO - Current Topics in Medicinal Chemistry
JF - Current Topics in Medicinal Chemistry
IS - 5
ER -